DSM licenses enzyme library from c-LEcta
This article was originally published in Scrip
DSM Pharmaceutical Products, the contract biopharmaceutical manufacturer, has entered into an agreement with c-LEcta of Germany to access it's proprietary collection of alcohol dehydrogenases (ADHs) for screening. ADHs they can be used for the synthesis of chiral alcohols widely used in pharmaceutical and fine-chemical industries, among other things.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.